Pantec Biosolutions Showcases P.L.E.A.S.E.® Professional at the IMCAS Annual Congress

RUGGELL, Liechtenstein--(BUSINESS WIRE)--Pantec Biosolutions AG, the developer and manufacturer of P.L.E.A.S.E.^® Professional, a state of the art portable laser device that sets new standards for safety, precision and versatility, today announced that it will present its recently launched P.L.E.A.S.E.^® Professional laser device at the International Master Course on Aging Skin (IMCAS) from 26^th-29^th January 2012 in Paris, France.

Pantec Biosolutions’ P.L.E.A.S.E.^® Professional is the world’s first break-through diode-pumped laser technology in the field of fractional ablative treatments for dermatology, aesthetic dermatology and transdermal drug delivery. The device is marketed in the European Union as a laser device for aesthetic skin rejuvenation, selected dermatological applications and combination treatments. Application tests are currently run at selected reference centers with the device and shipping of first production model devices is planned to start in March 2012.

Stefan Schubert, Business Manager of Dermatology at Pantec Biosolutions, said: “As IMCAS has become one of the most important international congresses dedicated to aging skin treatments, we are delighted to be able to introduce our P.L.E.A.S.E.^® Professional laser device to the attending dermatologists and plastic surgeons. We look forward to welcoming all interested IMCAS attendees at our exhibition stand (E24) to put their hands on a working P.L.E.A.S.E.^® Professional device in demonstration mode and collect more background information.”

If you would like to learn more about the P.L.E.A.S.E.^® Universe and its unique technology and functionality, please visit Pantec Biosolutions at Stand E24.

For more information on P.L.E.A.S.E.^® Professional, you can also visit: www.please-professional.com or Pantec Biosolutions’ corporate website: www.pantec-biosolutions.com

***

About Pantec Biosolutions and P.L.E.A.S.E.^® Professional

Pantec Biosolutions specializes in precise skin microporation technology. Our proprietary P.L.E.A.S.E.^® (Precise Laser EpidermAl SystEm) technology has been developed for:

• Conventional and aesthetic dermatology
• Transdermal drug delivery of large molecular weight drugs
• Combination treatments – e.g. microporation with a laser and topically applied bio-active substances

About the P.L.E.A.S.E.^® Platform

P.L.E.A.S.E.^® is a multi-application platform with an extendable treatment range for various applications. The platform significantly improves drug uptake in addition to reducing treatment duration, avoiding the need for injections and improving clinical outcome. The technology has significant potential to unlock a high unmet need of treatments requiring large molecular weight biopharmaceuticals.

About P.L.E.A.S.E.^® Professional

P.L.E.A.S.E.^® Professional is a state of the art bench top laser device that sets new standards for safety, precision and versatility. The advanced user interface and sophisticated software ensures convenient and simple touch-screen operation giving users the option of selecting either pre-stored parameters or customizing parameters themselves.

P.L.E.A.S.E.^® Professional is developed and manufactured by Pantec Biosolutions and was awarded a red dot design award in 2010. Pantec Biosolutions is located in Ruggell, Liechtenstein.

Pantec Biosolutions’ legal disclaimer: This communication expressly or implicitly contains certain forward-looking statements concerning Pantec Biosolutions and its business. Such statements involve certain known and unknown risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of Pantec Biosolutions to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Pantec Biosolutions is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise. The information contained in this communication does not constitute nor imply an offer to sell or transfer any product, and no product based on this technology is currently available for sale by Pantec Biosolutions in the United States or Canada. The analytical and clinical performance characteristics of any Pantec Biosolutions product based on this technology which may be sold at some future time in the U.S. have not been established.